Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy by Nasser Semmo, Michaela Lucas, George Krashias,

Slides:



Advertisements
Similar presentations
Volume 17, Issue 9, Pages (September 2015)
Advertisements

Supplementary Figure 3 Antigen-specific responses are enhanced by stimulation in an in vitro stimulation (IVS) assay, as well as with stimulation using.
T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a–specific, HLA-DRB3*0101–restricted CD4+ T cells by Maria Therese.
SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection by.
AAV-1–mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells by Federico Mingozzi, Janneke.
Melanoma donor (MD) NK cells are functionally impaired/exhausted.
Volume 122, Issue 5, Pages (May 2002)
Volume 19, Issue 12, Pages (December 2011)
Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators by Rikke Bæk Sørensen, Sine Reker Hadrup, Inge Marie Svane, Mads Christian.
by Masih Ostad, Margareta Andersson, Astrid Gruber, and Anne Sundblad
Identification of Autoantigen Epitopes in Alopecia Areata
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses by Giulia Nizzoli, Jana Krietsch, Anja Weick, Svenja.
Volume 132, Issue 2, Pages (February 2007)
Volume 138, Issue 2, Pages e2 (February 2010)
Identification of alloreactive T-cell epitopes on the Rhesus D protein
Further Analysis of Interleukin-2 Receptor Subunit Expression on the Different Human Peripheral Blood Mononuclear Cell Subsets by Denis David, Lynda Bani,
Volume 137, Issue 4, Pages (October 2009)
Volume 140, Issue 2, Pages e1 (February 2011)
Reconstitution of the Epstein-Barr virus–specific cytotoxic T-lymphocyte response following T-cell–depleted myeloablative and nonmyeloablative allogeneic.
CMV-, EBV- and ADV-Specific T Cell Immunity: Screening and Monitoring of Potential Third-Party Donors to Improve Post-Transplantation Outcome  Cinja Sukdolak,
Volume 149, Issue 6, Pages e2 (November 2015)
Impaired Responses of Peripheral Blood Mononuclear Cells to Staphylococcal Superantigen in Patients with Severe Atopic Dermatitis: A Role of T Cell Apoptosis 
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation by Ann M.
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants by Georg.
Volume 18, Issue 8, Pages (August 2010)
Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non–genotype 1 infection by Julian Schulze zur Wiesch,
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Volume 143, Issue 4, Pages e9 (October 2012)
Molecular Therapy - Nucleic Acids
Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15 by Maria Wysocka, Bernice M. Benoit, Sarah.
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products by David-Alexandre.
Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection by Katherine K. Wynn, Zara.
Longitudinal dynamics of antigen-specific CD8+cytotoxic T lymphocytes following primary Epstein-Barr virus infection by Mandvi Bharadwaj, Scott R. Burrows,
Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell–depleted stem cell transplantation.
Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia  Guenther.
Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo by Suzanne M. McGoldrick, Marie E. Bleakley,
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses by Cagan Gurer, Till.
Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets by Maria Nikolova, Jean-Daniel Lelievre, Matthieu.
ANCA patients have T cells responsive to complementary PR-3 antigen
Volume 28, Issue 5, Pages (May 2008)
Volume 17, Issue 9, Pages (September 2009)
Inflammation in common variable immunodeficiency is associated with a distinct CD8+ response to cytomegalovirus  Sayed Mahdi Marashi, PhD, Mohammad Raeiszadeh,
Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor.
Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens by Jie Yang, Victor M. Lemas, Ian W. Flinn, Chris.
Volume 38, Issue 2, Pages (February 2013)
Volume 22, Issue 5, Pages (May 2014)
Recovery of Varicella-Zoster Virus–Specific T Cell Immunity after T Cell–Depleted Allogeneic Transplantation Requires Symptomatic Virus Reactivation 
Cytomegalovirus Immune Reconstitution Occurs in Recipients of Allogeneic Hematopoietic Cell Transplants Irrespective of Detectable Cytomegalovirus Infection 
Volume 134, Issue 7, Pages e2 (June 2008)
Volume 132, Issue 2, Pages (February 2007)
Volume 22, Issue 3, Pages (March 2014)
Volume 124, Issue 7, Pages (June 2003)
Volume 19, Issue 11, Pages (November 2011)
Atul Sathe, Sterling B. Ortega, Dorothy I. Mundy, Robert H
Volume 127, Issue 3, Pages (September 2004)
TCF1 expression marks self-renewing human CD8+ T cells
Volume 39, Issue 4, Pages (October 2003)
Volume 134, Issue 7, Pages e2 (June 2008)
The Expression Pattern of Epstein-Barr Virus Latent Genes In Vivo Is Dependent upon the Differentiation Stage of the Infected B Cell  Gregory J Babcock,
Volume 147, Issue 4, Pages e8 (October 2014)
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study  D. Goletti, S. Carrara,
Volume 18, Issue 7, Pages (July 2010)
Volume 8, Issue 2, Pages (August 2003)
Quantitative and Qualitative CD4 T Cell Immune Responses Related to Adenovirus DNAemia in Hematopoietic Stem Cell Transplantation  Valérie Guérin-El Khourouj,
Human γ/δ T-cell proliferation and IFN-γ production induced by hexamethylene diisocyanate  Adam V Wisnewski, PhD, Christina A Herrick, MD, PhD, Qing Liu,
Defining antigen-specific responses with human MHC class II tetramers
Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation by Wayne R. Godfrey, Mark.
by Honglin Chen, Paul Smith, Richard F. Ambinder, and S. Diane Hayward
Increase in proliferation and activation of immune cells in peripheral blood after NKTR-214 treatment. Increase in proliferation and activation of immune.
Immunologic and pharmacokinetic studies.
Presentation transcript:

Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy by Nasser Semmo, Michaela Lucas, George Krashias, Georg Lauer, Helen Chapel, and Paul Klenerman Blood Volume 107(11):4570-4571 June 1, 2006 ©2006 by American Society of Hematology

Analysis of HCV-specific and other T-cell responses in hypogammaglobulinemic cohort. Analysis of HCV-specific and other T-cell responses in hypogammaglobulinemic cohort. (A) Percentage of positive responses to different antigens tested using a range of techniques. Numbers on top of each bar show absolute numbers of responding individuals tested for the various antigens. The numbers include those tested from the whole cohort, both PCR+ and PCR–. Matrix ELISpot indicates antigens tested were 58 pools containing 301 overlapping peptides (P1-P58) spanning the whole HCV genome; TT, tetanus toxoid, CMV-L, cytomegalovirus lysate; A2-EBV, Epstein Barr virus peptide HLA-A2–GLCTLVAML, A2-HCV, HCV peptide HLA-A2–CINGVCWTV; and A1 HCV, HCV peptide HLA-A1–ATDALMTGY. (B) Mean magnitude of antigen-specific T-cell responses in ELISpot. Magnitude is shown as IFN-γ spot-forming cells (SFCs)/106 peripheral blood mononuclear cells (PBMCs). For matrix ELISpot, mean number of reactive pools is 11 (range, 4-26 pools); mean magnitude is 137 SFC/106 PBMCs (range, 45-360 SFC/106 PBMCs). (A-B) The vertical line divides each graph into control antigens (left) and HCV antigens (right). (C) HCV-specific CD4+ proliferative responses as determined by the CFSE assay. Results are shown for 2 PCR– hypogammaglobulinemic individuals previously exposed to HCV (first patient in top panels; second patient in middle and bottom control panels). PBMCs were stimulated for 6 days using HCV core peptide pools and HCV nonstructural proteins NS3/4 and NS5 as described. Responses represent the percentage of proliferating CD4+ T cells after subtraction of the background (negative). Undivided CD4+ T cells are detected in the top right quadrants of each FACS plot, and the CFSE signal is diluted with each cell division as the dye is distributed to the daughter cells. Numbers in the top left quadrants of each plot represent the percentage of HCV peptide– or protein-specific CD4+ T cells that have proliferated during the 6-day culture. One negative and 1 positive (phytohemagglutinin [PHA]) control are shown in the bottom panel. Cells are gated on CD4+ and Viaprobe-negative (live) cells (Viaprobe; Becton Dickinson, San Diego, CA). Nasser Semmo et al. Blood 2006;107:4570-4571 ©2006 by American Society of Hematology